Symptom Differences and Pretreatment Asymptomatic Interval Affect Outcomes of Stenting for Intracranial Atherosclerotic Disease

References

1. 1.↵
   1. Jiang WJ,
   2. Cheng-Ching E,
   3. Abou-Chebl A,
   4. et al

   . Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery 2012;70:25–30

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Sacco RL,
   2. Kargman DE,
   3. Gu Q,
   4. et al

   . Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14–20

   Abstract/FREE Full Text
3. 3.↵
   1. Wong LK

   . Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158–59

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Derdeyn CP,
   4. et al

   . Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Hussain MS,
   2. Fraser JF,
   3. Abruzzo T,
   4. et al

   . Standard of practice: endovascular treatment of intracranial atherosclerosis. J Neurointerv Surg 2012;4:397–406

   Abstract/FREE Full Text
6. 6.↵
   1. Lutsep HL

   . Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–92

   Abstract/FREE Full Text
7. 7.↵
   1. Miao ZR,
   2. Feng L,
   3. Li S,
   4. et al

   . Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 2009;64:79–84

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Mori T,
   2. Kazita K,
   3. Chokyu K,
   4. et al

   . Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249–54

   Abstract/FREE Full Text
9. 9.↵
   1. Levy EI,
   2. Horowitz MB,
   3. Koebbe CJ,
   4. et al

   . Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215–23

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Gupta R,
    2. Schumacher HC,
    3. Mangla S,
    4. et al

    . Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729–35

    CrossRef
11. 11.↵
    1. Jiang WJ,
    2. Wang YJ,
    3. Du B,
    4. et al

    . Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375–80

    Abstract/FREE Full Text
12. 12.↵
    1. Bose A,
    2. Hartmann M,
    3. Henkes H,
    4. et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–37

    Abstract/FREE Full Text
13. 13.↵
    1. Gomez CR,
    2. Misra VK,
    3. Liu MW,
    4. et al

    . Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95–99

    Abstract/FREE Full Text
14. 14.↵
    1. Marks MP,
    2. Marcellus ML,
    3. Do HM,
    4. et al

    . Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005;26:525–30

    Abstract/FREE Full Text
15. 15.↵
    1. Marks MP,
    2. Wojak JC,
    3. Al-Ali F,
    4. et al

    . Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

    Abstract/FREE Full Text
16. 16.↵
    1. Yu W,
    2. Smith WS,
    3. Singh V,
    4. et al

    . Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64:1055–57

    CrossRef
17. 17.↵
    1. Kim DJ,
    2. Lee BH,
    3. Kim DI,
    4. et al

    . Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 2005;26:1381–88

    Abstract/FREE Full Text
18. 18.↵
    1. Fiorella D,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

    Abstract/FREE Full Text
19. 19.↵
    1. Fiorella DJ,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . Target lesion revascularization after Wingspan: assessment of safety and durability. Stroke 2009;40:106–10

    Abstract/FREE Full Text
20. 20.↵
    1. Henkes H,
    2. Miloslavski E,
    3. Lowens S,
    4. et al

    . Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222–28

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Levy EI,
    2. Turk AS,
    3. Albuquerque FC,
    4. et al

    . Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–50

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Nahab F,
    2. Lynn MJ,
    3. Kasner SE,
    4. et al

    . Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014–19

    CrossRef
23. 23.↵
    1. Turk AS,
    2. Levy EI,
    3. Albuquerque FC,
    4. et al

    . Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23–27

    Abstract/FREE Full Text
24. 24.↵
    1. Yu SCH,
    2. Leung TWH,
    3. Lee KT,
    4. et al

    . Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol 2011;32:753–58

    Abstract/FREE Full Text
25. 25.↵
    1. Zaidat OO,
    2. Klucznik R,
    3. Alexander MJ,
    4. et al

    . The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24

    CrossRef
26. 26.↵
    1. Kessler IM,
    2. Mounayer C,
    3. Piotin M,
    4. et al

    . The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol 2005;26:2342–48

    Abstract/FREE Full Text
27. 27.↵
    1. Hatano T,
    2. Tsukahara T,
    3. Ogino E,
    4. et al

    . Stenting for vertebrobasilar artery stenosis. Acta Neurochirurgica Suppl 2005;94:137–41

    CrossRef
28. 28.↵
    1. Lee TH,
    2. Kim DH,
    3. Lee BH,
    4. et al

    . Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2005;26:166–74

    Abstract/FREE Full Text
29. 29.↵
    1. Chow MM,
    2. Masaryk TJ,
    3. Woo HH,
    4. et al

    . Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 2005;26:869–74

    Abstract/FREE Full Text
30. 30.↵
    1. Lylyk P,
    2. Vila JF,
    3. Miranda C,
    4. et al

    . Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005;27(Suppl 1):S84–88

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Boulos AS,
    2. Agner C,
    3. Deshaies EM

    . Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 2005;27(Suppl 1):S95–S102

    CrossRefPubMed
32. 32.↵
    1. Abou-Chebl A,
    2. Bashir Q,
    3. Yadav JS

    . Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005;36:e165–e168

    Abstract/FREE Full Text
33. 33.↵
    1. Abou-Chebl A,
    2. Krieger DW,
    3. Bajzer CT,
    4. et al

    . Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 2006;16:216–23

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Costalat V,
    2. Maldonado IL,
    3. Vendrell JF,
    4. et al

    . Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results. J Neurosurg 2011;115:686–93

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Lanfranconi S,
    2. Bersano A,
    3. Branca V,
    4. et al

    . Stenting for the treatment of high-grade intracranial stenoses. J Neurol 2010;257:1899–908

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Zhao ZW,
    2. Deng JP,
    3. He SM,
    4. et al

    . Intracranial angioplasty with Gateway-Wingspan system for symptomatic atherosclerotic stenosis: preliminary results of 27 Chinese patients. Surg Neurol 2009;72:607–11

    CrossRefPubMed
37. 37.↵
    1. Chimowitz MI,
    2. Lynn MJ,
    3. Howlett-Smith H,
    4. et al

    . Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Mori T,
    2. Fukuoka M,
    3. Kazita K,
    4. et al

    . Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525–33

    Abstract
39. 39.↵
    1. Quinn J,
    2. Kramer N,
    3. McDermott D

    . Validation of the Social Security Death Index (SSDI): an important readily-available outcomes database for researchers. West J Emerg Med 2008;9:6–8

    PubMed
40. 40.↵
    1. Kasner SE,
    2. Chimowitz MI,
    3. Lynn MJ,
    4. et al

    . Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555–63

    Abstract/FREE Full Text
41. 41.↵
    1. Powers WJ,
    2. Clarke WR,
    3. Grubb RL Jr.,
    4. et al

    . Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the carotid occlusion surgery study randomized trial. JAMA 2011;306:1983–92

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Powers WJ,
    2. Grubb RL Jr.,
    3. Raichle ME

    . Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. J Neurosurg 1989;70:61–67

    CrossRefPubMed
43. 43.↵
    1. Nguyen TN,
    2. Zaidat OO,
    3. Gupta R,
    4. et al

    . Balloon angioplasty for intracranial atherosclerotic disease periprocedural risks and short-term outcomes in a multicenter study. Stroke 2011;42:107–11

    Abstract/FREE Full Text
44. 44.↵
    1. Chamczuk AJ,
    2. Ogilvy CS,
    3. Snyder KV,
    4. et al

    . Elective stenting for intracranial stenosis under conscious sedation. Neurosurgery 2010;67:1189–93

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Samaniego EA,
    2. Hetzel S,
    3. Thirunarayanan S,
    4. et al

    . Outcome of symptomatic intracranial atherosclerotic disease. Stroke 2009;40:2983–87

    Abstract/FREE Full Text
46. 46.↵
    1. Patel RD,
    2. Saver JL

    . Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a systematic, comparative analysis. Stroke 2013;44:94–98

    Abstract/FREE Full Text
47. 47.↵
    1. Tarr RW,
    2. Albuquerque F,
    3. Hirsh J,
    4. et al

    . The SAMMPRIS trial: the end or just the beginning. J Neurointerv Surg 2011;3:310–11

    FREE Full Text
48. 48.↵
    1. Shofti R,
    2. Tio F,
    3. Beyar R

    . Neointimal vascularization and intimal thickening in response to self-expanding stents: a swine model. Int J Cardiovasc Intervent 2004;6:61–67

    PubMed
49. 49.↵
    1. Fiorella D,
    2. Chow MM,
    3. Anderson M,
    4. et al

    . A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236–42

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Groschel K,
    2. Schnaudigel S,
    3. Pilgram SM,
    4. et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–347

    Abstract/FREE Full Text
51. 51.↵
    1. Yu SC,
    2. Leung TW,
    3. Lee KT,
    4. et al

    . Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients. J Neurointerv Surg 2014;6:212–18

    Abstract/FREE Full Text
52. 52.↵
    1. Rahme RJ,
    2. Aoun SG,
    3. Batjer HH,
    4. et al

    . SAMMPRIS: end of intracranial stenting for atherosclerosis or back to the drawing board? Neurosurgery 2011;69:N16–N18

    PubMed
53. 53.↵
    1. Rasmussen PA

    . Stroke outcome measures: a tale of two trials. J Neurointerv Surg 2013;5:393–94

    FREE Full Text